Filing Details
- Accession Number:
- 0001213900-18-009128
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-07-12 17:11:48
- Reporting Period:
- 2018-07-10
- Accepted Time:
- 2018-07-12 17:11:48
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1176309 | Oramed Pharmaceuticals Inc. | ORMP | Pharmaceutical Preparations (2834) | 980376008 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1351779 | Nadav Kidron | 142 W. 57Th St. New York NY 10019 | President And Ceo | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2018-07-10 | 61 | $5.98 | 958,087 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2018-07-11 | 122 | $5.92 | 958,209 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | P | Direct |
Footnotes
- On July 12, 2018, Mr. Kidron paid to Oramed Pharmaceuticals Inc. $3.88, representing the full amount of the profit realized in connection with these short-swing transactions.